TSS
OVID icon

Two Sigma Securities’s Ovid Therapeutics OVID Stock Holding History

Two Sigma Securities’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56.2K Buy
+25,324
New +$45.3K 0.01% 1253
2025
Q4 		– Sell
-11,698
Closed -$15.2K – 1871
2025
Q3 		$15.2K Buy
+11,698
New +$10.1K ﹤0.01% 1170

Other funds holding OVID

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Two Sigma Securities's OVID Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Ovid Therapeutics (OVID) in Q1 2026: 25,324 shares worth $56.2K. The stake represents 0.01% of the portfolio and ranks #1253 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in OVID as recently as Q3 2025.

Two Sigma Securities first reported a position in OVID in Q3 2025 and has held it in 2 quarters since. 103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

  • Two Sigma Securities held 25,324 shares of Ovid Therapeutics worth $56.2K as of Q1 2026.
  • Ovid Therapeutics was a new Two Sigma Securities position in Q1 2026.
  • Ovid Therapeutics made up 0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1253 holding.
  • Two Sigma Securities first reported a position in Ovid Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.